Fulltext

Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis

Wasserfallen, Jean-Blaise ; Halabi, Georges ; Saudan, Patrick ; Perneger, Thomas ; Feldman, Harold I. ; Martin, Pierre-Yves ; Wauters, Jean-Pierre

In: Nephrology Dialysis Transplantation, 2004, vol. 19, no. 6, p. 1594-1599

Ajouter à la liste personnelle
    Titre
    • Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis
    Auteur
    • Wasserfallen, Jean-Blaise. University Hospital Lausanne (CHUV), Lausanne
    • Halabi, Georges. University Hospital Lausanne (CHUV), Lausanne
    • Saudan, Patrick. University Hospital Geneva (HUG), Geneva, Switzerland and
    • Perneger, Thomas. University Hospital Geneva (HUG), Geneva, Switzerland and
    • Feldman, Harold I.. University of Pennsylvania Medical Center, Philadelphia, PA, USA
    • Martin, Pierre-Yves. University Hospital Geneva (HUG), Geneva, Switzerland and
    • Wauters, Jean-Pierre. University Hospital Lausanne (CHUV), Lausanne
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Nephrology Dialysis Transplantation, 2004, vol. 19, no. 6, p. 1594-1599. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:304296
    Summary
    Background. Quality of life (QOL) assessment in patients on chronic haemodialysis (HD) or peritoneal dialysis (PD) has only rarely been carried out with the generic Euroqol-5D® questionnaire. Methods. All chronic HD and PD patients in the 19 centres of western Switzerland were requested to fill in the validated Euroqol-5D® generic QOL questionnaire, assessing health status in five dimensions and on a visual analogue scale, allowing computation of a predicted QOL value, to be compared with the value measured on the visual analogue scale. Results. Of the 558 questionnaires distributed to chronic HD patients, 455 were returned (response rate 82%). Fifty of 64 PD patients (78%) returned the questionnaire. The two groups were similar in age, gender and duration of dialysis treatment. Mean QOL was rated at 60±18% for HD and 61±19% for PD, for a mean predicted QOL value of 62±30 and 58±32% respectively. Results of the five dimensions were similar in both groups, except for a greater restriction in usual activities for PD patients (P = 0.007). The highest scores were recorded for self-care, with 71% HD and 74% PD patients reporting no limitation, and the lowest scores for usual activities, with 14% HD and 23% PD patients reporting severe limitation. Experiencing pain/discomfort (for HD and PD) or anxiety/depression (for PD) had the highest impact on QOL. Conclusions. QOL was equally diminished in HD and PD patients. The questionnaire was well accepted and performed well. Improvement could be achievable in both groups if pain/discomfort and anxiety/depression could be more effectively treated